# Guangzhou PackGene Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-packgene-biotechnology-co

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.packgene.cn
- Total disclosed funding: $14M
- Latest round: Series C (Dec 1, 2023)
- Investors on record: 11

## About

Established in 2014 and based in Guangzhou, China, Guangzhou PackGene Biotechnology Co.,Ltd operates as an adeno-associated virus (AAV) R&D manufacturer, specializing in AAV viral vector packaging CRO and CDMO services. It has branch offices in Shanghai, Boston and Switzerland. Some enterprises and universities, such as Sun Yet-sun University, Einstein, and South Western Medical Center, have cooperated with the company. In July 2022, Genemagic Biosciences became the strategic partner of the company. In December 2023, PackGene Biotech closed a series C+ funding from CS Capital.

The company provides CRO and CDMO services focused on recombinant adeno-associated virus (AAV) vector packaging. CRO services include in-stock plasmid and AAV virus, AAV custom packaging, plasmid DNA cloning, plasmid extraction, AAV and plasmid analysis and testing services, and new crown research tools. CDMO services are divided into three series, which are plasmid CDMO services, AAV CDMO services, and CMC filing services. PackGene Biotech also developed a testing services platform and technology platform such as p-Alpha™ 293 cell AAV high yield technology platform, p-Omega™ plasmid DNA high yield platform, and p-Icosa™ AAV serotype screening platform.

## Funding rounds

- Series C, Dec 1, 2023, $14M — CS Capital
- Series C, Apr 18, 2023 — IFSC, Sanmei Capital, Guangzhou Guoju Venture Capital, Guangzhou Development District City Development Fund, Guangzhou Xinxing Fund
- Series B, Oct 23, 2020 — Hong Shan, Cathay Capital, Oriza Holdings, Decheng Capital
- Series B, Aug 12, 2020 — Cathay Capital, Oriza Holdings
- Series A, Feb 1, 2020 — Tengye Ventures

## Investors

- Tengye Ventures (https://capitalatlas.ai/funds/tengye-ventures) — Series A
- Cathay Capital — Series B
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series B
- Hong Shan — Series B
- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series B
- IFSC (https://capitalatlas.ai/funds/ifsc) — Series C
- Sanmei Capital (https://capitalatlas.ai/funds/sanmei-capital) — Series C
- Guangzhou Guoju Venture Capital (https://capitalatlas.ai/funds/guangzhou-guoju-venture-capital) — Series C
- Guangzhou Development District City Development Fund (https://capitalatlas.ai/funds/guangzhou-development-district-city-development-fund) — Series C
- Guangzhou Xinxing Fund (https://capitalatlas.ai/funds/guangzhou-xinxing-fund) — Series C
- CS Capital — Series C